25x-NBOMe: Difference between revisions
>BronzeManul m Corrected 'Federal Analog Act' to 'Federal Analogue Act'. |
>Unity Use headerpanel. Expand toxicity section with stub. 'Legality' -> 'Legal status' with stub. |
||
Line 1: | Line 1: | ||
{{Warning/25x-NBOMe}} | {{headerpanel|{{Warning/25x-NBOMe}}}} | ||
[[File:25x-NBOMe.png|301px|thumbnail|The general structure for a 25x-NBOMe compound]] | [[File:25x-NBOMe.png|301px|thumbnail|The general structure for a 25x-NBOMe compound]] | ||
'''25x-NBOMe''' is the general form of the NBOMe series of psychedelic [[phenethylamines]]. The series had nearly no history of human use before 2010 when some of the first compounds became available for purchase from online [[research chemical]] vendors. | '''25x-NBOMe''' is the general form of the NBOMe series of psychedelic [[phenethylamines]]. The series had nearly no history of human use before 2010 when some of the first compounds became available for purchase from online [[research chemical]] vendors. | ||
Line 35: | Line 35: | ||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
{{toxicity}} | |||
===Tolerance and addiction potential=== | |||
Members of the 25x-NBOMe series are not [[Addiction potential::not habit-forming]] and the desire to use them can actually decrease with use. They are thought to be mostly self-regulating. | |||
== | Tolerance to the effects of 25x-NBOMe is built [[Time to full tolerance::almost immediately after ingestion]]. After that, it takes about [[Time to half tolerance::1 week]] for the tolerance to be reduced to half and [[Time to zero tolerance::2 weeks]] to be back at baseline (in the absence of further consumption). 25x-NBOMe presents cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the consumption of 25I-NBOMe all psychedelics will have a reduced effect. | ||
===Dangerous interactions=== | |||
{{DangerousInteractions/Intro}} | |||
*'''[[Tramadol]]''' - Tramadol lowers the seizure threshold<ref>Talaie, H., Panahandeh, R., Fayaznouri, M. R., Asadi, Z., & Abdollahi, M. (2009). Dose-independent occurrence of seizure with tramadol. Journal of medical toxicology, 5(2), 63-67. doi:10.1007/BF03161089</ref> and [[psychedelics]] may act as triggers for seizures, particularly in those who are predisposed to them.{{citation needed}} | |||
*'''[[Stimulants]]''' - Stimulants affect many parts of the brain. Combined with psychedelics, stimulation can turn into uncontrollable [[anxiety]], [[Panic attacks|panic]], [[thought loops]] and [[paranoia]]. This interaction may cause elevated risk of psychosis.{{citation needed}} | |||
*'''[https://en.wikipedia.org/wiki/Lithium_(medication) Lithium]''' - Lithium is often used as treatment for bipolar disorder. It may possibly cause elevated risk of seizures and psychosis due to its [[Glutamate|glutaminergic]] and [[GABA|GABAergic]] effects.{{citation needed}} | |||
====[[Serotonin syndrome]] risk==== | |||
{{DangerousInteractions/SerotoninSyndrome}} | |||
==Legal status== | |||
{{legalStub}} | |||
*'''United States:''' In the US, some of the 25x-NBOMe chemicals are listed as Schedule I substances and others may be considered analogues under the Federal Analog Act.{{citation needed}} | *'''United States:''' In the US, some of the 25x-NBOMe chemicals are listed as Schedule I substances and others may be considered analogues under the Federal Analog Act.{{citation needed}} | ||
*'''United Kingdom''' - The majority of synthesised 25x-NBOMe substances are Class A drugs in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause.<ref>United Kingdom. (2014). Misuse of Drugs Act 1971 (S.I. 2014/1106). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/2014/1106/made</ref> Any compounds not covered by the clause are illegal to produce, supply, or import under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref> | *'''United Kingdom''' - The majority of synthesised 25x-NBOMe substances are Class A drugs in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause.<ref>United Kingdom. (2014). Misuse of Drugs Act 1971 (S.I. 2014/1106). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/2014/1106/made</ref> Any compounds not covered by the clause are illegal to produce, supply, or import under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref> | ||
Line 48: | Line 63: | ||
*[[2C-x]] | *[[2C-x]] | ||
*[[DOx]] | *[[DOx]] | ||
==Literature== | ==Literature== | ||
*Hansen, M., Phonekeo, K., Paine, J. S., Leth-Petersen, S., Begtrup, M., Bräuner-Osborne, H., & Kristensen, J. L. (2014). Synthesis and structure–activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. ACS Chemical Neuroscience, 5(3), 243-249. https://doi.org/10.1021/cn400216u | *Hansen, M., Phonekeo, K., Paine, J. S., Leth-Petersen, S., Begtrup, M., Bräuner-Osborne, H., & Kristensen, J. L. (2014). Synthesis and structure–activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. ACS Chemical Neuroscience, 5(3), 243-249. https://doi.org/10.1021/cn400216u |